NCT03388944

Brief Summary

The investigators' objective is to compare the risk of treatment failure\* in children admitted to the pediatric intensive care unit (PICU) with sepsis and managed by procalcitonin guided therapy for stopping of antibiotics ('PCT- guided therapy' group) with those managed with standard practices based on the evidence based guidelines ('control' group). Children with suspected or proven sepsis will be randomized to the PCT guided group or the standard practices group and will be followed up for the outcome measures that include treatment failure and mortality. The investigators plan to enroll 560 patients over a period of 3 years. The investigators believe that the proposed study will provide the answer to reducing unnecessary antibiotic usage in the PICU without causing any harm to the patient in the form of treatment failure and/or mortality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
561

participants targeted

Target at P75+ for not_applicable sepsis

Timeline
Completed

Started Oct 2019

Longer than P75 for not_applicable sepsis

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 18, 2017

Completed
5 months until next milestone

First Posted

Study publicly available on registry

January 3, 2018

Completed
1.8 years until next milestone

Study Start

First participant enrolled

October 21, 2019

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2023

Completed
Last Updated

March 3, 2025

Status Verified

February 1, 2025

Enrollment Period

3.4 years

First QC Date

August 18, 2017

Last Update Submit

February 27, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Treatment failure

    The primary outcome measure would be treatment failure\* (defined as growth of one or more of the initial causative organism(s) from a second sample taken within 48 hours after stopping antibiotics and/ or clinical signs or symptoms of infection) within 7 days of stoppage of antibiotics.

    From day of stopping first course of antibiotic therapy till day 7 after stopping antibiotics

Secondary Outcomes (3)

  • Proportion clinically cured

    From day of stopping first course of antibiotic therapy till day 7 of stopping therapy

  • Antibiotic free days

    Till day 28 of hospital stay

  • Mortality

    Till death or day 28 whichever is earlier

Study Arms (2)

PCT group

EXPERIMENTAL

PCT group

Behavioral: PCT group

Standard practice group

NO INTERVENTION

No intervention

Interventions

PCT groupBEHAVIORAL

In this group antibiotic therapy will be stopped based on serial PCT measurements starting from admission.

PCT group

Eligibility Criteria

Age2 Months - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children 2 month to 17 years admitted to the ICU and already receiving antibiotics for suspected or proven sepsis (defined as systemic inflammatory response syndrome or SIRS due to infection) and children who are started on antibiotics in the ICU for suspected or proven sepsis will be included.

You may not qualify if:

  • Children receiving antibiotics more than 24 hours before presentation
  • Children with severe immunosuppression (CD4 count of less than 200 cells/mm3, neutropenic patients (\<500 neutrophils/ml)) other than corticosteroid use
  • Children admitted for post-op observation
  • Children with an estimated length of stay less than 24 hrs
  • Children with underlying co-morbidities with possible imminent death
  • Children whose parents refuse to give an informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

St Johns Medical College and Hospital

Bengaluru, Karnataka, 560034, India

Location

PGIMER

Chandigarh, India

Location

Related Links

MeSH Terms

Conditions

SepsisShock, Septic

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShock

Study Officials

  • S K Kabra, MD

    All India Institute of Medical Sciences

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Children with suspected or proven sepsis will be randomized to the PCT guided group or the standard practices group and will be followed up for the primary outcome measure that includes treatment failure. We would also be comparing the duration of antibiotic therapy and mortality between the two groups as secondary outcome measures.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 18, 2017

First Posted

January 3, 2018

Study Start

October 21, 2019

Primary Completion

February 28, 2023

Study Completion

February 28, 2023

Last Updated

March 3, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations